The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dihydroartemisinin Market Research Report 2024
Synopsis
The global Dihydroartemisinin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dihydroartemisinin include Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource and Botanical Extracts EPZ Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dihydroartemisinin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dihydroartemisinin.
Report Scope
The Dihydroartemisinin market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dihydroartemisinin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dihydroartemisinin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
Segment by Type
Pharmaceutical Grade
Industrial Grade
Segment by Application
Malaria Treatment
Scientific Research
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dihydroartemisinin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dihydroartemisinin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dihydroartemisinin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global Dihydroartemisinin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dihydroartemisinin include Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource and Botanical Extracts EPZ Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dihydroartemisinin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dihydroartemisinin.
Report Scope
The Dihydroartemisinin market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dihydroartemisinin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dihydroartemisinin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
Segment by Type
Pharmaceutical Grade
Industrial Grade
Segment by Application
Malaria Treatment
Scientific Research
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dihydroartemisinin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dihydroartemisinin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dihydroartemisinin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Dihydroartemisinin Market Overview
1.1 Product Definition
1.2 Dihydroartemisinin Segment by Type
1.2.1 Global Dihydroartemisinin Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Pharmaceutical Grade
1.2.3 Industrial Grade
1.3 Dihydroartemisinin Segment by Application
1.3.1 Global Dihydroartemisinin Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Malaria Treatment
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Dihydroartemisinin Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Dihydroartemisinin Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Dihydroartemisinin Production Estimates and Forecasts (2019-2030)
1.4.4 Global Dihydroartemisinin Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Dihydroartemisinin Production Market Share by Manufacturers (2019-2024)
2.2 Global Dihydroartemisinin Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Dihydroartemisinin, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Dihydroartemisinin Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Dihydroartemisinin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Dihydroartemisinin, Product Offered and Application
2.8 Global Key Manufacturers of Dihydroartemisinin, Date of Enter into This Industry
2.9 Dihydroartemisinin Market Competitive Situation and Trends
2.9.1 Dihydroartemisinin Market Concentration Rate
2.9.2 Global 5 and 10 Largest Dihydroartemisinin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Dihydroartemisinin Production by Region
3.1 Global Dihydroartemisinin Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Dihydroartemisinin Production Value by Region (2019-2030)
3.2.1 Global Dihydroartemisinin Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Dihydroartemisinin by Region (2025-2030)
3.3 Global Dihydroartemisinin Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Dihydroartemisinin Production by Region (2019-2030)
3.4.1 Global Dihydroartemisinin Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Dihydroartemisinin by Region (2025-2030)
3.5 Global Dihydroartemisinin Market Price Analysis by Region (2019-2024)
3.6 Global Dihydroartemisinin Production and Value, Year-over-Year Growth
3.6.1 North America Dihydroartemisinin Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Dihydroartemisinin Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Dihydroartemisinin Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Dihydroartemisinin Production Value Estimates and Forecasts (2019-2030)
4 Dihydroartemisinin Consumption by Region
4.1 Global Dihydroartemisinin Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Dihydroartemisinin Consumption by Region (2019-2030)
4.2.1 Global Dihydroartemisinin Consumption by Region (2019-2024)
4.2.2 Global Dihydroartemisinin Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Dihydroartemisinin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Dihydroartemisinin Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Dihydroartemisinin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Dihydroartemisinin Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Dihydroartemisinin Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Dihydroartemisinin Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Dihydroartemisinin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Dihydroartemisinin Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Dihydroartemisinin Production by Type (2019-2030)
5.1.1 Global Dihydroartemisinin Production by Type (2019-2024)
5.1.2 Global Dihydroartemisinin Production by Type (2025-2030)
5.1.3 Global Dihydroartemisinin Production Market Share by Type (2019-2030)
5.2 Global Dihydroartemisinin Production Value by Type (2019-2030)
5.2.1 Global Dihydroartemisinin Production Value by Type (2019-2024)
5.2.2 Global Dihydroartemisinin Production Value by Type (2025-2030)
5.2.3 Global Dihydroartemisinin Production Value Market Share by Type (2019-2030)
5.3 Global Dihydroartemisinin Price by Type (2019-2030)
6 Segment by Application
6.1 Global Dihydroartemisinin Production by Application (2019-2030)
6.1.1 Global Dihydroartemisinin Production by Application (2019-2024)
6.1.2 Global Dihydroartemisinin Production by Application (2025-2030)
6.1.3 Global Dihydroartemisinin Production Market Share by Application (2019-2030)
6.2 Global Dihydroartemisinin Production Value by Application (2019-2030)
6.2.1 Global Dihydroartemisinin Production Value by Application (2019-2024)
6.2.2 Global Dihydroartemisinin Production Value by Application (2025-2030)
6.2.3 Global Dihydroartemisinin Production Value Market Share by Application (2019-2030)
6.3 Global Dihydroartemisinin Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Sanofi
7.1.1 Sanofi Dihydroartemisinin Corporation Information
7.1.2 Sanofi Dihydroartemisinin Product Portfolio
7.1.3 Sanofi Dihydroartemisinin Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Main Business and Markets Served
7.1.5 Sanofi Recent Developments/Updates
7.2 KPC Pharmaceuticals
7.2.1 KPC Pharmaceuticals Dihydroartemisinin Corporation Information
7.2.2 KPC Pharmaceuticals Dihydroartemisinin Product Portfolio
7.2.3 KPC Pharmaceuticals Dihydroartemisinin Production, Value, Price and Gross Margin (2019-2024)
7.2.4 KPC Pharmaceuticals Main Business and Markets Served
7.2.5 KPC Pharmaceuticals Recent Developments/Updates
7.3 Guangxi Xiancaotang Pharmaceutical
7.3.1 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Corporation Information
7.3.2 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product Portfolio
7.3.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Guangxi Xiancaotang Pharmaceutical Main Business and Markets Served
7.3.5 Guangxi Xiancaotang Pharmaceutical Recent Developments/Updates
7.4 Guilin Pharmaceutical
7.4.1 Guilin Pharmaceutical Dihydroartemisinin Corporation Information
7.4.2 Guilin Pharmaceutical Dihydroartemisinin Product Portfolio
7.4.3 Guilin Pharmaceutical Dihydroartemisinin Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Guilin Pharmaceutical Main Business and Markets Served
7.4.5 Guilin Pharmaceutical Recent Developments/Updates
7.5 Kerui Nanhai Pharmaceutical
7.5.1 Kerui Nanhai Pharmaceutical Dihydroartemisinin Corporation Information
7.5.2 Kerui Nanhai Pharmaceutical Dihydroartemisinin Product Portfolio
7.5.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Kerui Nanhai Pharmaceutical Main Business and Markets Served
7.5.5 Kerui Nanhai Pharmaceutical Recent Developments/Updates
7.6 Shanghai Natural Bio-engineering Co
7.6.1 Shanghai Natural Bio-engineering Co Dihydroartemisinin Corporation Information
7.6.2 Shanghai Natural Bio-engineering Co Dihydroartemisinin Product Portfolio
7.6.3 Shanghai Natural Bio-engineering Co Dihydroartemisinin Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Shanghai Natural Bio-engineering Co Main Business and Markets Served
7.6.5 Shanghai Natural Bio-engineering Co Recent Developments/Updates
7.7 Novanat Bioresource
7.7.1 Novanat Bioresource Dihydroartemisinin Corporation Information
7.7.2 Novanat Bioresource Dihydroartemisinin Product Portfolio
7.7.3 Novanat Bioresource Dihydroartemisinin Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Novanat Bioresource Main Business and Markets Served
7.7.5 Novanat Bioresource Recent Developments/Updates
7.8 Botanical Extracts EPZ Ltd
7.8.1 Botanical Extracts EPZ Ltd Dihydroartemisinin Corporation Information
7.8.2 Botanical Extracts EPZ Ltd Dihydroartemisinin Product Portfolio
7.8.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Botanical Extracts EPZ Ltd Main Business and Markets Served
7.7.5 Botanical Extracts EPZ Ltd Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Dihydroartemisinin Industry Chain Analysis
8.2 Dihydroartemisinin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Dihydroartemisinin Production Mode & Process
8.4 Dihydroartemisinin Sales and Marketing
8.4.1 Dihydroartemisinin Sales Channels
8.4.2 Dihydroartemisinin Distributors
8.5 Dihydroartemisinin Customers
9 Dihydroartemisinin Market Dynamics
9.1 Dihydroartemisinin Industry Trends
9.2 Dihydroartemisinin Market Drivers
9.3 Dihydroartemisinin Market Challenges
9.4 Dihydroartemisinin Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
